Clinical trial
Sodium Pyruvate Therapy in COPD Patients
NCT00262613 · Emphycorp, Industry · Completed
Key facts
| NCT number | NCT00262613 |
|---|---|
| Title | Sodium Pyruvate Therapy in COPD Patients |
| Official title | Long-Term Use of Inhaled Sodium Pyruvate for the Treatment of Chronic Obstructive Pulmonary Disease |
| Lead sponsor | Emphycorp, Industry |
| Collaborators | Cellular Sciences, inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Obstructive Pulmonary Disease (COPD) |
| Intervention type | Drug |
| Interventions | sodium pyruvate in 0.9% sodium chloride solution |
| Enrollment | 60 |
| Start date | Sep 1, 2004 |
| Completion | May 1, 2006 |
| First posted | Dec 7, 2005 |
| Last update posted | May 29, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: